Recovery from LCDD-associated Severe Liver Cholestasis: a Case Report and Literature Review
Benoît Brilland(Centre National de la Recherche Scientifique), Jean‐François Augusto(Centre National de la Recherche Scientifique), Johnny Sayegh(Université Nantes Angers Le Mans), Anne Croué(Centre Hospitalier Universitaire d'Angers), Frank Bridoux(Université de Poitiers), Jean‐François Subra(Centre National de la Recherche Scientifique)
Cited by 5
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520